Mercado de seccionamiento de tejidos: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00019692
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 181
Buy Now

Se prevé que el mercado de corte de tejidos alcance los 904,86 millones de dólares en 2028, frente a los 580,29 millones de dólares de 2021; se espera que crezca a una tasa compuesta anual del 6,6 % de 2021 a 2028.

La sección de tejido es un procedimiento que consiste en cortar tejidos en secciones delgadas para poder colocarlas en un portaobjetos y luego montado bajo un microscopio para su estudio. Se utiliza para examinar el tejido y detectar cualquier anomalía o enfermedad. Se emplea en laboratorios de histología, laboratorios de ciencias y otros entornos. El procesamiento del tejido se lleva a cabo después de que el tejido ha sido examinado entre la inclusión y la fijación del tejido.

El informe ofrece información y un análisis en profundidad del mercado del seccionamiento de tejido, enfatizando varios parámetros. tales como tendencias del mercado, avances tecnológicos, dinámica del mercado y análisis del panorama competitivo de los principales actores del mercado en todo el mundo. También incluye el impacto de la pandemia de COVID-19 en el mercado en todas las regiones. La pandemia ha alterado las condiciones socioeconómicas de varios países del mundo. Actualmente, Estados Unidos es el país más afectado del mundo debido al brote de COVID-19 y tiene el mayor número de casos confirmados y muertes, según las estadísticas recientes de la OMS. El elevado número de casos positivos de COVID-19 ha impactado negativamente a las economías globales. Ha habido una disminución en las actividades comerciales generales y el crecimiento de varias industrias que operan en todo el mundo.

Perspectivas estratégicas

Ha habido varios factores, incluido el aumento de la incidencia de pacientes positivos para COVID-19, el crecimiento de la investigación, el aumento de la producción de vacunas, el estudio de los resultados de las vacunas administradas y muchos otros factores. Por ejemplo, el Colegio de Patólogos Estadounidenses realizó una investigación para informar sobre las características demográficas y radiográficas de los pulmones de pacientes infectados y fallecidos con COVID-19 fatal. Todas las autopsias se realizaron en el Colegio de Patólogos Estadounidenses. El estudio reveló que los pacientes infectados con COVID-19 no solo tienen daño alveolar difuso sino que también comúnmente padecen bronconeumonía aguda y neumonía por aspiración. Los casos provocaron principalmente la demanda de pruebas de diagnóstico en países como Estados Unidos, Canadá y México. Por lo tanto, el mercado de corte de tejido en América del Norte se ve afectado positivamente por COVID-19.

Según la región, el mercado de corte de tejido está segmentado en América del Norte, Europa y Asia. Pacífico, Medio Oriente y Asia. África y América del Sur y Central.

regiones lucrativas para el mercado de seccionamiento de tejidos


  ;

Perspectivas del mercado

Adopción creciente de medicina personalizada  para impulsar el mercado de seccionamiento de tejidos

La medicina personalizada o de precisión se ha convertido en el sello distintivo del tratamiento de una serie de enfermedades graves y se ha expandido a otros campos con su aplicación. Es un enfoque constantemente emergente para personalizar terapias basadas en la acumulación genética de los pacientes. Estos avances tecnológicos han llevado a enfoques de corte de tejido que logran mejores resultados con los recursos disponibles en menos tiempo. Para la prevención y el tratamiento eficaz de una enfermedad, los medicamentos personalizados son herramientas imprescindibles, especialmente en los casos de oncología y nefrología. El rápido aumento de los casos de cáncer está contribuyendo indirectamente al crecimiento del mercado de corte de tejidos.

Por ejemplo, según la OMS, el cáncer es la principal causa de muerte en todo el mundo, lo que representa causante de casi 10 millones de muertes en 2020. El cáncer de pulmón, el cáncer de hígado, el cáncer de sangre y el cáncer de mama son los tipos de cáncer más comunes. Actualmente, entre el 30% y el 50% de los cánceres se pueden prevenir mediante un diagnóstico precoz y un tratamiento y atención adecuados de los pacientes. Muchos cánceres tienen altas posibilidades de curarse si se diagnostican a tiempo y se tratan adecuadamente, afirmó la OMS. El uso cada vez mayor de la medicina personalizada ha provocado un aumento en la demanda de uso de tejido humano para fomentar pruebas innovadoras.

Información basada en productos

Basado en producto, el mercado de seccionamiento de tejidos se clasifica en instrumentos, accesorios y accesorios. consumibles y servicios. El segmento de instrumentos representó la mayor parte del mercado. El segmento de instrumentos se subsegmenta en microtomo rotatorio, microtomo deslizante, ultramicrotomo, criostato y otros.  

Mercado de seccionamiento de tejidos, por producto: 2021 y 2028


Información basada en tecnología

Basado en la tecnología, el mercado de seccionamiento de tejidos Se divide en automática, semiautomática y manual. El segmento de tecnología automática tendría la mayor participación del mercado en 2021, y se estima que el mismo segmento registrará la CAGR más alta del mercado del 7,0% durante el período de pronóstico.

Información basada en aplicaciones

Según la aplicación, el mercado del seccionamiento de tejidos se segmenta en diagnóstico e investigación. En 2021, el segmento de diagnóstico tendría la mayor cuota de mercado. Además, también se espera que el segmento de investigación experimente un crecimiento a la CAGR más rápida del 7,2 % entre 2021 y 2028.

Información basada en el usuario final

Según el usuario final, el mercado de seccionamiento de tejidos se segmenta en hospitales, instituciones de investigación y otros. El segmento de instituciones de investigación tendría la mayor participación del mercado en 2021, y se prevé que el mismo segmento registre la CAGR más alta del 10,9% del mercado durante el período de pronóstico.

Los actores del mercado de corte de tejidos adoptan estrategias orgánicas, como el lanzamiento y la expansión de productos, para ampliar su presencia y cartera de productos en todo el mundo y satisfacer la creciente demanda.

Por producto< /h3>
  • Instrumentos
    • Microtomo rotatorio
    • Ultramicrotomo
    • Criostato
    • Microtomo deslizante
    • Otros
  • Accesorios y Consumibles
  • Servicios

Por Tecnología

  • Automático
  • Semiautomático
  • Manual

Por Aplicación

  • Diagnóstico
  • Investigación

Por usuario final

  • Hospitales
  • Clínicas
  • Laboratorios de diagnóstico
  • Digital Path Labs
  • Otros

Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Italia< /li>
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • Israel
  • América del Sur y Central (SCAM )
    • Brasil

Perfiles de empresas

  • Thermo Fisher Científico
  • Leica Biosystems Nussloch GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • Sakura Finetek Europe BV
  • Diapath SpA
  • Laboratorios Histo-line
  • Medite Medical GmbH
  • SLEE medical GmbH
  • Abcam plc
  • Amas Scientific Pty Ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the potential market for tissue sectioning in terms of the region?

Asia Pacific registered as the fastest-growing region in the global tissue sectioning market. The market is this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, expanding R&D, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the tissue sectioning market players to grow during the forecast period.

What are the drivers and restraints for the tissue sectioning market?

The growth of the market is attributed to the increasing prevalence of chronic diseases and the rising adoption of personalized medicine drives the market growth. However, the lack of skilled professionals hampers the market growth.

Who are the key players in the tissue sectioning market?

The disposable pipettes tips market majorly consists of players like Thermo Fisher Scientific; Leica Biosystems Nussloch GmbH; LLS ROWIAK LaserLabSolutions GmbH; Sakura Finetek Europe B.V; Diapath S.p.A.; Histo-line Laboratories; Medite Medical GmbH; SLEE medical GmbH; Abcam plc; and Amas Scientific Pty Ltd among others.

Who are the key end-users of the tissue sectioning market?

The hospitals, clinics, diagnostic laboratories, digital path labs, and others are the key end-users of the tissue sectioning market. In 2021, the hospital’s segment is likely to hold the largest share of the market. However, the diagnostic laboratories segment is also expected to witness growth in its demand at the fastest CAGR of 7.1% from 2021 to 2028.

What is the market CAGR value of the tissue sectioning market during the forecast period?

The global tissue sectioning market is expected to reach US$ 904.86 million in 2028 from US$ 580.29 million in 2021. The market is estimated to grow with a CAGR of 6.6% from 2021-2028.

The List of Companies - Tissue Sectioning Market

  1. Thermo Fisher Scientific
  2. Leica Biosystems Nussloch GmbH
  3. LLS ROWIAK LaserLabSolutions GmbH
  4. Sakura Finetek Europe B.V
  5. Diapath S.p.A.
  6. Histo-line Laboratories
  7. Medite Medical GmbH
  8. SLEE medical GmbH
  9. Abcam plc
  10. Amas Scientific Pty Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports